Who owns Xbiotech?
- Ticker: XBIT
- CUSIP Number: 98400h102
Tip: Access positions for across all investors
Analyze quarterly positions in Xbiotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xbiotech stock
Who bought or sold Xbiotech this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 416k | $1.1M | -24% | Sep 2025 |
|
| Vanguard Group | 300k | $716k | -63% | Dec 2025 |
|
| BlackRock | 289k | $690k | -5% | Dec 2025 |
|
| Geode Capital Management | 221k | $529k | 0% | Dec 2025 |
|
| Rbf Capital | 200k | $532k | 0% | Sep 2025 |
|
| Ameriprise Financial | 187k | $446k | 100% | Dec 2025 |
|
| Northern Trust | 76k | $183k | -6% | Dec 2025 |
|
| State Street Corporation | 73k | $175k | 8% | Dec 2025 |
|
| Jane Street | 70k | $167k | 25% | Dec 2025 |
|
| Squarepoint Ops | 64k | $153k | 3% | Dec 2025 |
|
| Empowered Funds | 60k | $142k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 60k | $158k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 51k | $121k | -21% | Dec 2025 |
|
| Bank of New York Mellon | 49k | $116k | 0% | Dec 2025 |
|
| Citadel Advisors | 43k | $115k | 32% | Sep 2025 |
|
| Connor, Clark & Lunn Investment Management | 30k | $72k | -16% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 27k | $64k | 30% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 25k | $59k | 0% | Dec 2025 |
|
| XTX Topco | 22k | $52k | 44% | Dec 2025 |
|
| Qube Research & Technologies | 21k | $49k | -32% | Dec 2025 |
|
| American Century Companies | 19k | $45k | 0% | Dec 2025 |
|
| Goldman Sachs Group | 17k | $40k | -33% | Dec 2025 |
|
| Two Sigma Advisers | 16k | $43k | 0% | Sep 2025 |
|
| Persistent Asset Partners | 14k | $32k | 100% | Dec 2025 |
|
| TNB Financial | 13k | $32k | 0% | Dec 2025 |
|
| Pinnacle Financial Partners | 12k | $28k | 100% | Dec 2025 |
|
| Synovus Financial Corp. | 12k | $31k | 0% | Sep 2025 |
|
| Two Sigma Securities | 10k | $25k | 100% | Dec 2025 |
|
| Point72 Asia | 6.8k | $18k | -50% | Sep 2025 |
|
| Cubist Systematic Strategies | 5.3k | $14k | -79% | Sep 2025 |
|
| UBS Group | 5.1k | $12k | -22% | Dec 2025 |
|
| Royal Bank of Canada | 2.8k | $10k | 15% | Sep 2025 |
|
| Jpmorgan Chase & Co | 2.4k | $6.3k | 100% | Sep 2025 |
|
| Rhumbline Advisers | 928.00 | $2.2k | 0% | Dec 2025 |
|
| McIlrath & Eck | 753.00 | $1.8k | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 370.00 | $884.004000 | 0% | Dec 2025 |
|
| FMR | 310.00 | $825.003000 | -84% | Sep 2025 |
|
| Simplex Trading | 67.00 | $160.002700 | -79% | Dec 2025 |
|
| CWM | 23.00 | $0 | -82% | Dec 2025 |
|
| Larson Financial Group | 21.00 | $50.001000 | 0% | Dec 2025 |
|
| Optiver Holding B.V. | 8.00 | $19.000000 | 0% | Dec 2025 |
|
| Barclays | 1.00 | $2.000000 | 100% | Dec 2025 |
|
| SBI Securities | 1.00 | $2.000000 | 0% | Dec 2025 |
|
Who sold out of Xbiotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Sep 2025 | 26k | $69k |
| SRS Capital Advisors | Sep 2025 | 22.00 | $58.000800 |
| EverSource Wealth Advisors | Sep 2025 | 17.00 | $45.000700 |
| True Wealth Design | Sep 2025 | 3.00 | $8.000100 |
| Sunbelt Securities | Sep 2025 | 2.00 | $5.000000 |